1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-20 of 25 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritisProudman, S.; Cleland, L.; Metcalf, R.; Sullivan, T.; Spargo, L.; James, M.
2016Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high doseHill, C.; March, L.; Aitken, D.; Lester, S.; Battersby, R.; Hynes, K.; Fedorova, T.; Proudman, S.; James, M.; Cleland, L.; Jones, G.
2012Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low doseProudman, S.; Spargo, L.; Hall, C.; McWilliams, L.; Lee, A.; Rischmueller, M.; Gibson, R.; James, M.; Cleland, L.G.; 2012 ACR/ARHP Annual Meeting (9 Nov 2012 - 14 Nov 2012 : Washington, D.C.)
2015Synovial fluid and plasma n3 long chain polyunsaturated fatty acids in patients with inflammatory arthritisMoghaddami, M.; James, M.; Proudman, S.; Cleland, L.
2003A Biomarker of n-3 compliance in patients taking fish oil for rheumatoid arthritisCleland, L.; Proudman, S.; Hall, C.; Stamp, L.; McWilliams, L.; Wylie, N.; Neumann, M.; Gibson, R.; James, M.
2007Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug useProudman, S.; Keen, H.; Stamp, L.; Lee, A.; Goldblatt, F.; Ayres, O.; Rischmueller, M.; James, M.; Hill, C.; Caughey, G.; Cleland, L.
2011Fatty acid desaturase 2 promoter mutation is not responsible for Δ6-desaturase deficiencyGregory, M.; Lester, S.; Cook-Johnson, R.; Gibson, R.; Proudman, S.; Cleland, L.; James, M.
2003Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritisJames, M.; Proudman, S.; Cleland, L.
2008Dietary omega-3 fats for treatment of inflammatory joint disease: Efficacy and utilityProudman, S.; Cleland, L.; James, M.
2011Quantitation of total and free teriflunomide (A77 1726) in human plasma by LC-MS/MSRakhila, H.; Rozek, T.; Hopkins, A.; Proudman, S.; Cleland, L.; James, M.; Wiese, M.

Discover